Advocacy at a Glance STEVEN GROSSMAN 6/26/20 Advocacy at a Glance STEVEN GROSSMAN 6/26/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More Advocacy at a Glance STEVEN GROSSMAN 6/12/20 Advocacy at a Glance STEVEN GROSSMAN 6/12/20 House and Senate Set Schedule for FY 21 Appropriations Mark-Ups Read More Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Procedural Path Cleared for House Mark-up Appropriations; Impediments Remain Read More Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Virtual Mark-ups: Prerequisite for Movement of Appropriations Bills Read More Advocacy at a Glance STEVEN GROSSMAN 5/8/20 Advocacy at a Glance STEVEN GROSSMAN 5/8/20 House and Senate Appropriations Committees Still Committed, Off to a Slow Start Read More Advocacy at a Glance STEVEN GROSSMAN 9/13/19 Advocacy at a Glance STEVEN GROSSMAN 9/13/19 Senate Appropriations to Mark-Up Ag/FDA Bill on Tuesday, September 17 Read More Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Budget Deal Passes Senate, President Agrees to Sign Read More Analysis and Commentary STEVEN GROSSMAN 5/23/19 Analysis and Commentary STEVEN GROSSMAN 5/23/19 House Mark-up for FY 20 Very Pleasing Read More Advocacy at a Glance STEVEN GROSSMAN 5/23/19 Advocacy at a Glance STEVEN GROSSMAN 5/23/19 House Subcommittee Proposes $184 million (6%) Increase for FDA’s FY 20 BA (Taxpayer) Funding Read More Advocacy at a Glance STEVEN GROSSMAN 4/12/19 Advocacy at a Glance STEVEN GROSSMAN 4/12/19 Hearings on FDA’s Budget are Completed. What Next? Read More Analysis and Commentary STEVEN GROSSMAN 5/11/18 Analysis and Commentary STEVEN GROSSMAN 5/11/18 The Good Start Continues ... Let's Show Appreciation Read More Advocacy at a Glance STEVEN GROSSMAN 5/11/18 Advocacy at a Glance STEVEN GROSSMAN 5/11/18 House Appropriations Bill Provides FDA with a $300+ Million Increase and more Read More Analysis and Commentary STEVEN GROSSMAN 5/13/16 Analysis and Commentary STEVEN GROSSMAN 5/13/16 Guarded Optimism -- With No Crystal Ball Read More Advocacy at a Glance STEVEN GROSSMAN 5/13/16 Advocacy at a Glance STEVEN GROSSMAN 5/13/16 Senate Ag/FDA Appropriations to Be Marked Up May 17 and 19 Read More Advocacy at a Glance STEVEN GROSSMAN 4/15/16 Advocacy at a Glance STEVEN GROSSMAN 4/15/16 Full House Appropriations Committee Action and more Read More Advocacy at a Glance STEVEN GROSSMAN 4/1/16 Advocacy at a Glance STEVEN GROSSMAN 4/1/16 FDA’s Generics Performance Report and more Read More
Advocacy at a Glance STEVEN GROSSMAN 6/26/20 Advocacy at a Glance STEVEN GROSSMAN 6/26/20 Upcoming Webinar with CBER Director Peter Marks, MD Read More
Advocacy at a Glance STEVEN GROSSMAN 6/12/20 Advocacy at a Glance STEVEN GROSSMAN 6/12/20 House and Senate Set Schedule for FY 21 Appropriations Mark-Ups Read More
Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Advocacy at a Glance STEVEN GROSSMAN 5/22/20 Procedural Path Cleared for House Mark-up Appropriations; Impediments Remain Read More
Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Advocacy at a Glance STEVEN GROSSMAN 5/15/20 Virtual Mark-ups: Prerequisite for Movement of Appropriations Bills Read More
Advocacy at a Glance STEVEN GROSSMAN 5/8/20 Advocacy at a Glance STEVEN GROSSMAN 5/8/20 House and Senate Appropriations Committees Still Committed, Off to a Slow Start Read More
Advocacy at a Glance STEVEN GROSSMAN 9/13/19 Advocacy at a Glance STEVEN GROSSMAN 9/13/19 Senate Appropriations to Mark-Up Ag/FDA Bill on Tuesday, September 17 Read More
Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Advocacy at a Glance STEVEN GROSSMAN 8/2/19 Budget Deal Passes Senate, President Agrees to Sign Read More
Analysis and Commentary STEVEN GROSSMAN 5/23/19 Analysis and Commentary STEVEN GROSSMAN 5/23/19 House Mark-up for FY 20 Very Pleasing Read More
Advocacy at a Glance STEVEN GROSSMAN 5/23/19 Advocacy at a Glance STEVEN GROSSMAN 5/23/19 House Subcommittee Proposes $184 million (6%) Increase for FDA’s FY 20 BA (Taxpayer) Funding Read More
Advocacy at a Glance STEVEN GROSSMAN 4/12/19 Advocacy at a Glance STEVEN GROSSMAN 4/12/19 Hearings on FDA’s Budget are Completed. What Next? Read More
Analysis and Commentary STEVEN GROSSMAN 5/11/18 Analysis and Commentary STEVEN GROSSMAN 5/11/18 The Good Start Continues ... Let's Show Appreciation Read More
Advocacy at a Glance STEVEN GROSSMAN 5/11/18 Advocacy at a Glance STEVEN GROSSMAN 5/11/18 House Appropriations Bill Provides FDA with a $300+ Million Increase and more Read More
Analysis and Commentary STEVEN GROSSMAN 5/13/16 Analysis and Commentary STEVEN GROSSMAN 5/13/16 Guarded Optimism -- With No Crystal Ball Read More
Advocacy at a Glance STEVEN GROSSMAN 5/13/16 Advocacy at a Glance STEVEN GROSSMAN 5/13/16 Senate Ag/FDA Appropriations to Be Marked Up May 17 and 19 Read More
Advocacy at a Glance STEVEN GROSSMAN 4/15/16 Advocacy at a Glance STEVEN GROSSMAN 4/15/16 Full House Appropriations Committee Action and more Read More
Advocacy at a Glance STEVEN GROSSMAN 4/1/16 Advocacy at a Glance STEVEN GROSSMAN 4/1/16 FDA’s Generics Performance Report and more Read More
